[PDF][PDF] Resistance to mesenchymal reprogramming sustains clonal propagation in metastatic breast cancer

…, HD Moreno, E Donato, M Falcone, JM Bartsch… - Cell reports, 2023 - cell.com
The acquisition of mesenchymal traits is considered a hallmark of breast cancer progression.
However, the functional relevance of epithelial-to-mesenchymal transition (EMT) remains …

Maintenance of epithelial traits and resistance to mesenchymal reprogramming promote proliferation in metastatic breast cancer

…, M Saini, HD Moreno, C Klein, JM Bartsch, M Falcone… - BioRxiv, 2020 - biorxiv.org
Despite important advances in the treatment of breast cancer, the 5-year survival rate for
patients with distant metastasis remains less than 30%. Metastasis is a complex, multi-step …

[HTML][HTML] Stem-cell-like properties and epithelial plasticity arise as stable traits after transient Twist1 activation

JM Schmidt, E Panzilius, HS Bartsch, M Irmler… - Cell reports, 2015 - cell.com
Master regulators of the epithelial-mesenchymal transition such as Twist1 and Snail1 have
been implicated in invasiveness and the generation of cancer stem cells, but their persistent …

Ranibizumab in retinopathy of prematurity–one‐year follow‐up of ophthalmic outcomes and two‐year follow‐up of neurodevelopmental outcomes from the CARE …

…, D Stavropoulou, J Tautz, K Bartsch… - Acta …, 2022 - Wiley Online Library
Purpose The primary endpoint results from the comparing alternative ranibizumab dosages
for safety and efficacy in retinopathy of prematurity (CARE‐ROP) core study identified …

Assessment of Retinopathy of Prematurity Regression and Reactivation Using an Artificial Intelligence–Based Vascular Severity Score

…, D Stavropolou, J Tautz, K Bartsch… - JAMA Network …, 2023 - jamanetwork.com
Importance One of the biggest challenges when using anti–vascular endothelial growth
factor (VEGF) agents to treat retinopathy of prematurity (ROP) is the need to perform long-term …

[HTML][HTML] Molecular karyotyping and gene expression analysis in childhood cancer patients

…, H Thomas, SK Peter, C Heather, M Johanna… - Journal of Molecular …, 2020 - Springer
The genetic etiology of sporadic childhood cancer cases remains unclear. We recruited a
cohort of 20 patients who survived a childhood malignancy and then developed a second …

The Dark Side of Media-An Interdisciplinary Approach to Elucidate the Persistence of Negative Experiences with the Smartphone in Everyday Life

M Bartsch - 2021 - ediss.sub.uni-hamburg.de
Have you ever had a negative experience with media? Do you keep using them, nonetheless?
Why?—Why would you use a medium again if use is most likely accompanied by …

[PDF][PDF] Comprehensive molecular characterization of pheochromocytoma and paraganglioma

…, R Baertsch, M Balasundaram, S Balu, DK Bartsch… - Cancer cell, 2017 - cell.com
We report a comprehensive molecular characterization of pheochromocytomas and
paragangliomas (PCCs/PGLs), a rare tumor type. Multi-platform integration revealed that PCCs/…

Comparing alternative ranibizumab dosages for safety and efficacy in retinopathy of prematurity: a randomized clinical trial

A Stahl, TU Krohne, N Eter, I Oberacher-Velten… - JAMA …, 2018 - jamanetwork.com
Importance Anti–vascular endothelial growth factor (VEGF) therapies are a novel treatment
option in retinopathy of prematurity (ROP). Data on dosing, efficacy, and safety are insufficient…

We thank our 2015 manuscript reviewers for their hard work and dedication. We also thank retiring Associate Editor Mark A. Merrick, PhD, ATC, FNATA, and Editorial …

…, J Barrett, JT Barth, AA Bartsch… - Journal of Athletic …, 2016 - meridian.allenpress.com
… Barth, PhD, ABCN Adam Bartsch, PhD, PE Christine M. Baugh, MPH David M. Bazett-Jones,
PhD, LAT, … Hoch, ATC Johanna M. Hoch, PhD, ATC Matthew C. Hoch, PhD, ATC Julie A. …